NioBay Intercepts Niobium in the Extension of Its Main Zone at Crevier
MONTRÉAL, Jan. 08, 2024 (GLOBE NEWSWIRE) — NioBay Metals inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased […]
LSL Pharma Group Announces an Extension of its Convertible Debentures Offering
BOUCHERVILLE, Québec, Jan. 08, 2024 (GLOBE NEWSWIRE) — LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma […]
Abercrombie & Fitch Co. Increases Fourth Quarter Sales and Operating Margin Outlook Based on Better-Than-Expected Holiday Sales
NEW ALBANY, Ohio, Jan. 08, 2024 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) today provided a business update, […]
Le CN annonce la nomination de Rémi G. Lalonde au poste de vice-président exécutif
MONTRÉAL, 08 janv. 2024 (GLOBE NEWSWIRE) — Le CN (TSX : CNR) (NYSE : CNI) a annoncé aujourd’hui la nomination de Rémi G. Lalonde […]
CN Announces Remi G. Lalonde as Executive Vice-President
MONTREAL, Jan. 08, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) today announced the appointment of Remi G. Lalonde […]
Collective Metals Announces Results of Phase II Soil Geochemical Sampling Program on its Princeton Project
Highlights Company has received final assays from Phase II of its two-phase 2023 soil-sampling program Phase II Program extends two […]
Carrols Restaurant Group, Inc. Reports Preliminary Sales Results for the Fourth Quarter and Full Year 2023
SYRACUSE, N.Y., Jan. 08, 2024 (GLOBE NEWSWIRE) — Carrols Restaurant Group, Inc. (“Carrols” or the “Company”) (Nasdaq: TAST), the largest […]
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
– Industry-leading PK Activator Franchise Has Demonstrated Clinical Efficacy in Four Hematological Diseases, Including New Positive Phase 3 Data in […]
G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference
– Initial Data from the Ongoing Phase 2 Trial in Combination with the Antibody-Drug Conjugate (ADC) Sacituzumab Govitecan (SG) Suggest […]
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
SAN MATEO, Calif. and SINGAPORE, Jan. 08, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (NASDAQ: ASLN) (“ASLAN” or the “Company”), announced […]
